⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Ethyl Propionate SCHEMBL1868177 | 1.00 | GAA (0.67) | — | |
| Ethyl Propionate SCHEMBL1332690 | 1.00 | — | — | |
| Ethyl Propionate SCHEMBL16045 | 1.00 | — | — | |
| Ethyl Propionate SCHEMBL10576295 | 0.97 | — | — | |
| Ethyl Propionate SCHEMBL19376923 | 0.97 | GAA (0.63) | — | |
| Ethyl Propionate SCHEMBL25183273 | 0.97 | — | — | |
| Ethyl Propionate SCHEMBL4449050 | 0.97 | — | — | |
| Ethyl Propionate SCHEMBL1161554 | 0.97 | — | — | |
| Ethyl Propionate SCHEMBL25298294 | 0.97 | — | — | |
| Ethyl Propionate SCHEMBL7036034 | 0.97 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 27 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20080311099-A1 | Pyridoxal-5-Phosphate and Related Compounds in Combination With Therapeutic Cardiovascular Compounds for Treating Angina | MEDICURE INTERNATIONAL INC. | 2008-12-18 | — | — | US | disclosed |
| WO-2007121588-A1 | TREATMENT OF ATRIAL FIBRILLATION | MEDICURE INTERNATIONAL INC. (BB) | 2007-11-01 | — | — | WO | disclosed |
| US-20070249562-A1 | TREATMENT OF ATRIAL FIBRILLATION | MEDICURE INTERNATIONAL INC. (CA) | 2007-10-25 | — | — | US | disclosed |
| US-20070167411-A1 | Compositions for treating angina | MEDICURE INTERNATIONAL INC. (BB) | 2007-07-19 | — | — | US | disclosed |
| US-7230009-B2 | Pyridoxal analogues and methods of treatment | MEDICURE, INC. (CA) | 2007-06-12 | — | — | US | disclosed |
| US-20070032456-A1 | Modulation of cell death | MEDICURE INC. (CA) | 2007-02-08 | — | — | US | disclosed |
| EP-1169322-B8 | PYRIDOXAL ANALOGUES FOR THE TREATMENT OF DISORDERS CAUSED BY A DEFICIENCY IN VITAMIN B6 | MEDICURE INC (CA) | 2006-09-13 | — | — | EP | disclosed |
| EP-1640005-A2 | Pyridoxal analogues for the treatment of disorders caused by a deficiency in vitamin B6 | Medicure International Inc. (CA) | 2006-03-29 | — | — | EP | disclosed |
| US-20060019929-A1 | Combination therapies employing platelet aggregation drugs | MEDICURE INTERNATIONAL INC. (CA) | 2006-01-26 | — | — | US | disclosed |
| EP-1610783-A2 | MODULATION OF CELL DEATH | Medicure Inc. (CA) | 2006-01-04 | — | — | EP | disclosed |
| US-20030195236-A1 | Pyridoxal analogues and methods of treatment | MEDICURE INC. (CA) | 2003-10-16 | — | — | US | disclosed |
| US-6586414-B2 | Administering pyridoxal-5'-phosphate, pyridoxal, pyridoxine, pyridoxamine, 3-acylated analogues thereof; treatment of strokes | MEDICURE INTERNATIONAL INC. (BB) | 2003-07-01 | — | — | US | disclosed |
| US-20030114424-A1 | Treatment of cerebrovascular disease | MEDICURE INTERNATIONAL INC. (BB) | 2003-06-19 | — | — | US | disclosed |
| EP-1278526-A2 | TREATMENT OF CEREBROVASCULAR DISEASE | Medicure International Inc. (BB) | 2003-01-29 | — | — | EP | disclosed |
| US-6339085-B1 | FOR THERAPY OF HYPERTROPHY, HYPERTENSION, CONGESTIVE HEART FAILURE, MYOCARDIAL ISCHEMIA, ARRHYTHMIA, HEART FAILURE SUBSEQUENT TO MYOCARDIAL INFARCTION, MYOCARDIAL INFARCTION, ISCHEMIA REPERFUSION INJURY, BLOOD COAGULATION | THE UNIVERSITY OF MANITOBA (CA) | 2002-01-15 | — | — | US | disclosed |
| EP-1169322-A1 | PYRIDOXAL ANALOGUES FOR VITAMIN B-6 DISORDERS | Medicure Inc. (CA) | 2002-01-09 | — | — | EP | disclosed |
| US-20010056081-A1 | Treatment of cerebrovascular disease | MEDICURE INTERNATIONAL INC. (CA) | 2001-12-27 | — | — | US | disclosed |
| US-20010031770-A1 | Pyridoxal analogues and methods of treatment | MEDICURE INC. (CA) | 2001-10-18 | — | — | US | disclosed |
| WO-2001072309-A2 | TREATMENT OF CEREBROVASCULAR DISEASE | MEDICURE INTERNATIONAL INC. (US) | 2001-10-04 | — | — | WO | disclosed |
| WO-2000053606-A1 | PYRIDOXAL ANALOGUES FOR VITAMIN B-6 DISORDERS | MEDICURE INC. (CA) | 2000-09-14 | — | — | WO | disclosed |